Status:
UNKNOWN
Chemoradiotherapy for Recurrent T1G3 Bladder Cancer
Lead Sponsor:
Assiut University
Conditions:
Bladder Cancer
Eligibility:
All Genders
40+ years
Phase:
PHASE4
Brief Summary
To evaluate the short term results of chemoradiation in case of T1G3 BC after BCG failure.
Detailed Description
Non- muscle invasive bladder cancer (NMIBC) is a heterogeneous group of cancers. For most urologists the treatment of T1G3 tumor poses a dilemma of management.The spectrum of clinical behavior include...
Eligibility Criteria
Inclusion
- All patients with recurrent T1G3 bladder cancer after 6 doses of BCG consenting for chemoradiation and refusing radical cystectomy
Exclusion
- Any patients with distant metastasis or positive LN on CT or MRI.
- Patients unfit for chemoradiation
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03274284
Start Date
October 1 2017
End Date
December 1 2019
Last Update
September 11 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.